S&P 500   3,947.35 (+1.18%)
DOW   31,759.82 (+1.59%)
QQQ   291.75 (+1.06%)
AAPL   142.16 (+3.32%)
MSFT   259.80 (+2.87%)
FB   194.18 (+0.33%)
GOOGL   2,220.58 (+1.95%)
AMZN   2,110.00 (-1.94%)
TSLA   666.17 (+0.34%)
NVDA   166.50 (-0.26%)
BABA   86.59 (-0.23%)
NIO   15.67 (-4.68%)
AMD   93.46 (-0.04%)
CGC   5.22 (-5.43%)
MU   69.18 (+0.41%)
T   20.82 (+2.06%)
GE   75.78 (+0.70%)
F   12.80 (+2.40%)
DIS   104.72 (+2.25%)
AMC   11.64 (-3.24%)
PFE   53.03 (+1.07%)
PYPL   81.01 (+0.58%)
NFLX   184.27 (-1.12%)
S&P 500   3,947.35 (+1.18%)
DOW   31,759.82 (+1.59%)
QQQ   291.75 (+1.06%)
AAPL   142.16 (+3.32%)
MSFT   259.80 (+2.87%)
FB   194.18 (+0.33%)
GOOGL   2,220.58 (+1.95%)
AMZN   2,110.00 (-1.94%)
TSLA   666.17 (+0.34%)
NVDA   166.50 (-0.26%)
BABA   86.59 (-0.23%)
NIO   15.67 (-4.68%)
AMD   93.46 (-0.04%)
CGC   5.22 (-5.43%)
MU   69.18 (+0.41%)
T   20.82 (+2.06%)
GE   75.78 (+0.70%)
F   12.80 (+2.40%)
DIS   104.72 (+2.25%)
AMC   11.64 (-3.24%)
PFE   53.03 (+1.07%)
PYPL   81.01 (+0.58%)
NFLX   184.27 (-1.12%)
S&P 500   3,947.35 (+1.18%)
DOW   31,759.82 (+1.59%)
QQQ   291.75 (+1.06%)
AAPL   142.16 (+3.32%)
MSFT   259.80 (+2.87%)
FB   194.18 (+0.33%)
GOOGL   2,220.58 (+1.95%)
AMZN   2,110.00 (-1.94%)
TSLA   666.17 (+0.34%)
NVDA   166.50 (-0.26%)
BABA   86.59 (-0.23%)
NIO   15.67 (-4.68%)
AMD   93.46 (-0.04%)
CGC   5.22 (-5.43%)
MU   69.18 (+0.41%)
T   20.82 (+2.06%)
GE   75.78 (+0.70%)
F   12.80 (+2.40%)
DIS   104.72 (+2.25%)
AMC   11.64 (-3.24%)
PFE   53.03 (+1.07%)
PYPL   81.01 (+0.58%)
NFLX   184.27 (-1.12%)
S&P 500   3,947.35 (+1.18%)
DOW   31,759.82 (+1.59%)
QQQ   291.75 (+1.06%)
AAPL   142.16 (+3.32%)
MSFT   259.80 (+2.87%)
FB   194.18 (+0.33%)
GOOGL   2,220.58 (+1.95%)
AMZN   2,110.00 (-1.94%)
TSLA   666.17 (+0.34%)
NVDA   166.50 (-0.26%)
BABA   86.59 (-0.23%)
NIO   15.67 (-4.68%)
AMD   93.46 (-0.04%)
CGC   5.22 (-5.43%)
MU   69.18 (+0.41%)
T   20.82 (+2.06%)
GE   75.78 (+0.70%)
F   12.80 (+2.40%)
DIS   104.72 (+2.25%)
AMC   11.64 (-3.24%)
PFE   53.03 (+1.07%)
PYPL   81.01 (+0.58%)
NFLX   184.27 (-1.12%)
LON:HZD

Horizon Discovery Group plc (HZD.L) (HZD) Share Forecast, Price & News

GBX 184.50
0.00 (0.00%)
(As of 12/23/2020)
Add
Compare
Today's Range
184.50
184.75
50-Day Range
184.50
184.50
52-Week Range
88.40
200
Volume
50,000 shs
Average Volume
676,498 shs
Market Capitalization
£302.98 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
N/A
30 days | 90 days | 365 days | Advanced Chart
Receive HZD News and Ratings via Email

Sign-up to receive the latest news and ratings for Horizon Discovery Group plc (HZD.L) and its competitors with MarketBeat's FREE daily newsletter.

Horizon Discovery Group plc (HZD.L) logo

About Horizon Discovery Group plc (HZD.L)

Horizon Discovery Group plc, a cell engineering company, engages in the design, manufacture, and application of gene editing and gene modulation tools in the United Kingdom, the United States, Europe, the Middle East, Africa, the Asia-Pacific, and internationally. The company operates through Screening, Research Reagents, Diagnostics, and BioProduction segments. It provides custom-made and off-the-shelf (OTS) RNAi gene modulation reagents, CRISPR reagents, synthetic SGRNAs, OTS cell models, and custom cell engineering services. The company also offers pooled CRISPR screens; arrayed RNAi and CRISPR screens, drug screens, and immunology assays; and RNAi and CRISPR screening libraries; and human T-Cell CRISPR screening service to meet the requirements of immunology based research in drug discovery. In addition, it provides OTS gene-edited CHO cells and custom CHO cell lines, and custom CHO gene engineering services; and OTS cell-based reference standards, made to order reference standards, and custom cell-based reference standards to evaluate molecular assays on a research use basis. The company serves customers in academic research labs, biopharmaceutical and diagnostics companies, and contract research and manufacturing organizations. It sells its products through direct field sales channel and e-commerce platform. The company has a partnership with the Rutgers, The State University of New Jersey to develop and commercialize base editing, a gene editing technology; strategic collaboration with Mammoth Biosciences to develop CRISPR tools to provide engineered cell lines for the biopharmaceutical industry; and collaboration with St George's University Hospital, London, and the European Molecular Genetics Quality Network to develop reference material for non-invasive prenatal testing. Horizon Discovery Group plc was founded in 2007 and is headquartered in Cambridge, the United Kingdom.

Headlines

Horizon Discovery Group Plc Regulatory News
See More Headlines

Industry, Sector and Symbol

Industry
Biotechnology
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
416
Year Founded
N/A

Sales & Book Value

Annual Sales
£54.63 million
Cash Flow
GBX 14.88 per share
Book Value
GBX 83.10 per share

Profitability

Pretax Margin
N/A

Debt

Price-To-Earnings

Miscellaneous

Free Float
N/A
Market Cap
£302.98 million
Optionable
Not Optionable

MarketRank

Overall MarketRank

0.99 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.9Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -













Horizon Discovery Group plc (HZD.L) (LON:HZD) Frequently Asked Questions

Who are Horizon Discovery Group plc (HZD.L)'s key executives?
Horizon Discovery Group plc (HZD.L)'s management team includes the following people:
  • Mr. Terence William Pizzie, CEO & Director (Age 59, Pay $687.56k)
  • Mr. Jayesh Pankhania, CFO, Sec. & Director
  • Dr. Chris Torrance, Co-Founder & Member of Scientific Advisory Board
  • Prof. Alberto Bardelli, Co-Founder & Chairman of Scientific Advisory Board
  • Ms. Kim Nichols, Head of Global Operations
  • Mr. Jon Davies, Head of Investor Relations
  • Mr. Chris Claxton, VP of Investor Relations & Corp. Communications
  • Dr. Brian Burke, Global Head of Strategy & Corp. Devel.
  • Ms. Julie Cormack, Global Head of HR
  • Dr. Chris Lowe, Head of Research Operations
What other stocks do shareholders of Horizon Discovery Group plc (HZD.L) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Horizon Discovery Group plc (HZD.L) investors own include Flowgroup (FLOW), Faron Pharmaceuticals Oy (FARN), Yamana Gold (YRI), Barkerville Gold Mines Ltd. (BGM.V) (BGM), (CELG), Eldorado Gold (ELD), Games Workshop Group (GAW), Polo Resources (POL), Silvercorp Metals (SVM) and Alamos Gold (AGI).

What is Horizon Discovery Group plc (HZD.L)'s stock symbol?

Horizon Discovery Group plc (HZD.L) trades on the London Stock Exchange (LON) under the ticker symbol "HZD."

How do I buy shares of Horizon Discovery Group plc (HZD.L)?

Shares of HZD and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Horizon Discovery Group plc (HZD.L)'s stock price today?

One share of HZD stock can currently be purchased for approximately GBX 184.50.

How much money does Horizon Discovery Group plc (HZD.L) make?

Horizon Discovery Group plc (HZD.L) has a market capitalization of £302.98 million and generates £54.63 million in revenue each year.

How many employees does Horizon Discovery Group plc (HZD.L) have?

Horizon Discovery Group plc (HZD.L) employs 416 workers across the globe.

What is Horizon Discovery Group plc (HZD.L)'s official website?

The official website for Horizon Discovery Group plc (HZD.L) is www.horizondiscovery.com.

How can I contact Horizon Discovery Group plc (HZD.L)?

Horizon Discovery Group plc (HZD.L)'s mailing address is 8100 Cambridge Research Park Beach Drive, CAMBRIDGE, CB25 9TL, United Kingdom. The company can be reached via phone at +44-1223-976000.

This page was last updated on 5/23/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.